CliffBio
small molecule

AMOXICILLIN AND CLAVULANATE POTASSIUM

AMOXICILLIN; CLAVULANATE POTASSIUM

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMOXICILLIN AND CLAVULANATE POTASSIUM
Active ingredientAMOXICILLIN; CLAVULANATE POTASSIUM
Strength250MG;EQ 125MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2009
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.